116 related articles for article (PubMed ID: 10638836)
1. Expression patterns of integrin receptors and extracellular matrix proteins in chronic rejection of human liver allografts.
Demirci G; Hoshino K; Nashan B
Transpl Immunol; 1999 Dec; 7(4):229-37. PubMed ID: 10638836
[TBL] [Abstract][Full Text] [Related]
2. Expression of cell-matrix molecules and integrin receptors in human liver grafts during chronic rejection.
Hoshino K; Nashan B; Steinhoff G; Pichlmayr R
Transpl Int; 1994; 7 Suppl 1():S637-40. PubMed ID: 11271327
[TBL] [Abstract][Full Text] [Related]
3. Fibrosis in chronic rejection of human liver allografts: expression patterns of transforming growth factor-TGFbeta1 and TGF-beta3.
Demirci G; Nashan B; Pichlmayr R
Transplantation; 1996 Dec; 62(12):1776-83. PubMed ID: 8990362
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix receptors and the differentiation of human megakaryocytes in vitro.
Molla A; Mossuz P; Berthier R
Leuk Lymphoma; 1999 Mar; 33(1-2):15-23. PubMed ID: 10194117
[TBL] [Abstract][Full Text] [Related]
5. Human skin mast cells express functional beta 1 integrins that mediate adhesion to extracellular matrix proteins.
Columbo M; Bochner BS; Marone G
J Immunol; 1995 Jun; 154(11):6058-64. PubMed ID: 7538541
[TBL] [Abstract][Full Text] [Related]
6. Role of inflammation in allogeneic and xenogeneic heart valve degeneration: immunohistochemical evaluation of inflammatory endothelial cell activation.
Wilhelmi MH; Mertsching H; Wilhelmi M; Leyh R; Haverich A
J Heart Valve Dis; 2003 Jul; 12(4):520-6. PubMed ID: 12918857
[TBL] [Abstract][Full Text] [Related]
7. Clinical implication of vascular cell adhesion molecule-1 and very late activation antigen-4 interaction, and matrix metalloproteinase-2 production in patients with liver disease.
Haruta I; Tokushige K; Komatsu T; Ikeda I; Yamauchi K; Hayashi N
Can J Gastroenterol; 1999 Nov; 13(9):721-7. PubMed ID: 10633824
[TBL] [Abstract][Full Text] [Related]
8. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
[TBL] [Abstract][Full Text] [Related]
9. Expression of adhesion molecules and their ligands in liver allografts during cytomegalovirus (CMV) infection and acute rejection.
Lautenschlager I; Höckerstedt K; Taskinen E; von Willebrand E
Transpl Int; 1996; 9 Suppl 1():S213-5. PubMed ID: 8959830
[TBL] [Abstract][Full Text] [Related]
10. VLA family in rheumatoid arthritis: evidence for in vivo regulated adhesion of synovial fluid T cells to fibronectin through VLA-5 integrin.
García-Vicuña R; Humbría A; Postigo AA; López-Elzaurdia C; de Landázuri MO; Sánchez-Madrid F; Laffón A
Clin Exp Immunol; 1992 Jun; 88(3):435-41. PubMed ID: 1376652
[TBL] [Abstract][Full Text] [Related]
11. Cross-species interaction of porcine and human integrins with their respective ligands: implications for xenogeneic tolerance induction.
Simon AR; Warrens AN; Yazzie NP; Seebach JD; Sachs DH; Sykes M
Transplantation; 1998 Aug; 66(3):385-94. PubMed ID: 9721809
[TBL] [Abstract][Full Text] [Related]
12. Expression of beta 1 integrins in human dental pulp in vivo: a comparative immunohistochemical study on healthy and chronic marginal periodontitis samples.
Taşman F; Ataç A; Er N; Dağdeviren A; Kendir B
Int Endod J; 2001 Jan; 34(1):11-5. PubMed ID: 11307375
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of cytokine-induced neutrophil chemoattractant in rat hepatic allografts during acute rejection.
Yamaguchi Y; Ichiguchi O; Matsumura F; Akizuki E; Matsuda T; Okabe K; Yamada S; Liang J; Mori K; Ogawa M
Hepatology; 1997 Dec; 26(6):1546-52. PubMed ID: 9397996
[TBL] [Abstract][Full Text] [Related]
14. Regulated expression of p150,95 (CD11c/CD18; alpha X/beta 2) and VLA-4 (CD49d/CD29; alpha 4/beta 1) integrins during myeloid cell differentiation.
Bellón T; López-Rodríguez C; Rubio MA; Jochems G; Bernabeu C; Corbi AL
Eur J Immunol; 1994 Jan; 24(1):41-7. PubMed ID: 8020569
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix proteins and VLA integrins expression in the microenvironment of human lung carcinoma.
Zeromski J; Lawniczak M; Mizera-Nyczak E; Zocchi MR
Pol J Pathol; 1995; 46(2):63-9. PubMed ID: 7543797
[TBL] [Abstract][Full Text] [Related]
16. Expression of the membrane attack complex of complement and its inhibitors during human liver allograft transplantation.
Conti F; Grude P; Calmus Y; Scoazec JY
J Hepatol; 1997 Nov; 27(5):881-9. PubMed ID: 9382976
[TBL] [Abstract][Full Text] [Related]
17. The expression of VLA integrins in the human thymus.
Karaöz E; Ilgaz C; Erdoğan D; Dağdeviren A
Ann Anat; 1996 Jan; 178(1):33-40. PubMed ID: 8717325
[TBL] [Abstract][Full Text] [Related]
18. A hierarchy for integrin expression and adhesiveness among T cell subsets that is linked to TCR gene usage and emphasizes V delta 1+ gamma delta T cell adherence and tissue retention.
Nakajima S; Roswit WT; Look DC; Holtzman MJ
J Immunol; 1995 Aug; 155(3):1117-31. PubMed ID: 7636183
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of extracellular matrix proteins and integrins in hepatocellular carcinoma and chronic liver disease.
Jaskiewicz K; Chasen MR; Robson SC
Anticancer Res; 1993; 13(6A):2229-37. PubMed ID: 8297138
[TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix proteins, integrin receptors (VLA-beta 1, VLA-alpha 2 and VLA-alpha 5) and growth fraction in atypical macroregenerative nodules of the liver: an immunocytochemical case study.
Patriarca C; Roncalli M; Viale G; Alfano RM; Braidotti P; Guddo F; Coggi G
Histochemistry; 1994 Aug; 102(1):29-36. PubMed ID: 7814267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
